This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

WEX To Serve As Presenting Sponsor Of Maine Cancer Foundation’s Tri For A Cure For 2013, 2014 And 2015

Stocks in this article: WXS

WEX Inc. (NYSE: WXS), a leading international provider of physical, digital and virtual corporate card payment solutions, today announced that it will serve as the Presenting Sponsor of the Tri for a Cure event for Maine Cancer Foundation (MCF), a statewide source of cancer grant funding, from 2013 to 2015. At the invitation of MCF executive director, Tara Hill, WEX chairman, president and CEO, Michael E. Dubyak, delivered opening remarks to a group of more than 250 business leaders at the Portland Regional Chamber of Commerce breakfast on December 5 announcing the three year gift.

“Maine Cancer Foundation is deeply committed to cancer research, education and patient support ― and WEX is deeply committed to its mission to find a cure and to support the people of Maine who find themselves affected by this disease,” said Dubyak. “It was our honor and our privilege to serve as the MCF Tri for a Cure Presenting Sponsor in 2012, a record-breaking event that raised $1,200,000. We made the decision to sponsor the Tri for a Cure for the next three years for many reasons including the fact that 100% of funds raised by Maine Cancer Foundation stay in Maine and are reinvested back in our community.”

“We are deeply appreciative of all that WEX has done for MCF and the Maine community and we look forward to making an even greater impact together through the Tri for a Cure event over the next three years,” said Tara Hill, executive director of MCF. “Investing in organizations like MCF is a triple-win for the business community in that it provides outlets for community involvement, actively attracts talent and federal money to the state, and it has a serious and lasting effect on medical research for cancer ― the No. 1 cause of death in our state.”

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.13 +48.24 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs